{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T22:15:28Z","timestamp":1783376128340,"version":"3.54.6"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"28","license":[{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Creative Youth Science Fund Project of Fujian Provincial Natural Science Foundation of China"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,7,28]]},"DOI":"10.1038\/s41388-026-03843-4","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T09:57:15Z","timestamp":1780739835000},"page":"2779-2794","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MCCC2 stabilizes LTBP1 via suppressing SMURF1-dependent ubiquitination to drive bone metastasis in prostate cancer"],"prefix":"10.1038","volume":"45","author":[{"given":"Minsheng","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shufen","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangqiang","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenping","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8928-6636","authenticated-orcid":false,"given":"Weiyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,6]]},"reference":[{"key":"3843_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. A Cancer J Clin. 2024;74:12\u201349.","journal-title":"A Cancer J Clin"},{"key":"3843_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215927","volume":"550","author":"J Liu","year":"2022","unstructured":"Liu J, Dong L, Zhu Y, Dong B, Sha J, Zhu HH, et al. Prostate cancer treatment - China\u2019s perspective. Cancer Lett. 2022;550:215927.","journal-title":"Cancer Lett"},{"key":"3843_CR3","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s00774-023-01435-w","volume":"41","author":"K Nishimura","year":"2023","unstructured":"Nishimura K. Management of bone metastasis in prostate cancer. J Bone Miner Metab. 2023;41:317\u201326.","journal-title":"J Bone Miner Metab"},{"key":"3843_CR4","doi-asserted-by":"crossref","unstructured":"Wells KV, Krackeler ML, Jathal MK, Parikh M, Ghosh PM, Leach JK, et al. Prostate cancer and bone: clinical presentation and molecular mechanisms. Endoc Relat Cancer. 2023; 30:e220360.","DOI":"10.1530\/ERC-22-0360"},{"key":"3843_CR5","doi-asserted-by":"publisher","first-page":"6063","DOI":"10.7150\/thno.36735","volume":"9","author":"Y Dai","year":"2019","unstructured":"Dai Y, Wu Z, Lang C, Zhang X, He S, Yang Q, et al. Copy number gain of ZEB1 mediates a double-negative feedback loop with miR-33a-5p that regulates EMT and bone metastasis of prostate cancer dependent on TGF-\u03b2 signaling. Theranostics. 2019;9:6063\u201379.","journal-title":"Theranostics"},{"key":"3843_CR6","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.ijbiomac.2022.02.094","volume":"206","author":"S Mirzaei","year":"2022","unstructured":"Mirzaei S, Paskeh MDA, Saghari Y, Zarrabi A, Hamblin MR, Entezari M, et al. Transforming growth factor-beta (TGF-\u03b2) in prostate cancer: a dual function mediator? Int J Biol Macromol. 2022;206:435\u201352.","journal-title":"Int J Biol Macromol"},{"key":"3843_CR7","doi-asserted-by":"crossref","unstructured":"Chen WY, Tsai YC, Yeh HL, Suau F, Jiang KC, Shao AN et al. Loss of SPDEF and gain of TGFBI activity after androgen deprivation therapy promote EMT and bone metastasis of prostate cancer. Sci signal. 2017; 10:eaam6826.","DOI":"10.1126\/scisignal.aam6826"},{"key":"3843_CR8","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41419-019-1750-7","volume":"10","author":"X Liu","year":"2019","unstructured":"Liu X, Chen L, Fan Y, Hong Y, Yang X, Li Y, et al. IFITM3 promotes bone metastasis of prostate cancer cells by mediating activation of the TGF-\u03b2 signaling pathway. Cell Death Dis. 2019;10:517.","journal-title":"Cell Death Dis"},{"key":"3843_CR9","first-page":"81","volume":"157","author":"K Miyazono","year":"1991","unstructured":"Miyazono K, Heldin CH. Latent forms of TGF-beta: molecular structure and mechanisms of activation. Ciba Found Symp. 1991;157:81\u201389. discussion 89-92.","journal-title":"Ciba Found Symp"},{"key":"3843_CR10","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S1043-2760(02)00615-X","volume":"13","author":"T Gumienny","year":"2002","unstructured":"Gumienny T, Padgett RW. The other side of TGF-beta superfamily signal regulation: thinking outside the cell. Trends Endocrinol Metab. 2002;13:295\u20139.","journal-title":"Trends Endocrinol Metab"},{"key":"3843_CR11","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0092-8674(00)80545-0","volume":"96","author":"JS Munger","year":"1999","unstructured":"Munger JS, Huang X, Kawakatsu H, Griffiths MJ, Dalton SL, Wu J, et al. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell. 1999;96:319\u201328.","journal-title":"Cell"},{"key":"3843_CR12","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1080\/15548627.2017.1422850","volume":"14","author":"J N\u00fcchel","year":"2018","unstructured":"N\u00fcchel J, Ghatak S, Zuk AV, Illerhaus A, M\u00f6rgelin M, Sch\u00f6nborn K, et al. TGFB1 is secreted through an unconventional pathway dependent on the autophagic machinery and cytoskeletal regulators. Autophagy. 2018;14:465\u201386.","journal-title":"Autophagy"},{"key":"3843_CR13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.molcel.2019.09.018","volume":"77","author":"Q Zhao","year":"2020","unstructured":"Zhao Q, Zheng K, Ma C, Li J, Zhuo L, Huang W, et al. PTPS facilitates compartmentalized LTBP1 S-nitrosylation and promotes tumor growth under hypoxia. Mol Cell. 2020;77:95\u2013107.e105.","journal-title":"Mol Cell"},{"key":"3843_CR14","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1038\/ncb3613","volume":"19","author":"X Zhuang","year":"2017","unstructured":"Zhuang X, Zhang H, Li X, Li X, Cong M, Peng F, et al. Differential effects on lung and bone metastasis of breast cancer by Wnt signalling inhibitor DKK1. Nat Cell Biol. 2017;19:1274\u201385.","journal-title":"Nat Cell Biol"},{"key":"3843_CR15","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1172\/JCI11948","volume":"107","author":"MR Baumgartner","year":"2001","unstructured":"Baumgartner MR, Almashanu S, Suormala T, Obie C, Cole RN, Packman S, et al. The molecular basis of human 3-methylcrotonyl-CoA carboxylase deficiency. J Clin Investig. 2001;107:495\u2013504.","journal-title":"J Clin Investig"},{"key":"3843_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2020.104428","volume":"115","author":"W Dai","year":"2020","unstructured":"Dai W, Feng H, Lee D. MCCC2 overexpression predicts poorer prognosis and promotes cell proliferation in colorectal cancer. Exp Mol Pathol. 2020;115:104428.","journal-title":"Exp Mol Pathol"},{"key":"3843_CR17","doi-asserted-by":"publisher","first-page":"7317","DOI":"10.2147\/OTT.S249906","volume":"13","author":"J He","year":"2020","unstructured":"He J, Mao Y, Huang W, Li M, Zhang H, Qing Y, et al. Methylcrotonoyl-CoA Carboxylase 2 promotes proliferation, migration and invasion and inhibits apoptosis of prostate cancer cells through regulating GLUD1-P38 MAPK signaling pathway. OncoTargets Ther. 2020;13:7317\u201327.","journal-title":"OncoTargets Ther"},{"key":"3843_CR18","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s11658-023-00487-0","volume":"28","author":"W Liu","year":"2023","unstructured":"Liu W, Chen S, Xie W, Wang Q, Luo Q, Huang M, et al. MCCC2 is a novel mediator between mitochondria and telomere and functions as an oncogene in colorectal cancer. Cell Mol Biol Lett. 2023;28:80.","journal-title":"Cell Mol Biol Lett"},{"key":"3843_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.103058","volume":"61","author":"X Liu","year":"2020","unstructured":"Liu X, Sun C, Zou K, Li C, Chen X, Gu H, et al. Novel PGK1 determines SKP2-dependent AR stability and reprograms granular cell glucose metabolism facilitating ovulation dysfunction. EBioMedicine. 2020;61:103058.","journal-title":"EBioMedicine"},{"key":"3843_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.426","volume":"11","author":"C Lang","year":"2021","unstructured":"Lang C, Yin C, Lin K, Li Y, Yang Q, Wu Z, et al. m(6) A modification of lncRNA PCAT6 promotes bone metastasis in prostate cancer through IGF2BP2-mediated IGF1R mRNA stabilization. Clin Transl Med. 2021;11:e426.","journal-title":"Clin Transl Med"},{"key":"3843_CR21","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.eururo.2019.06.030","volume":"76","author":"A Paschalis","year":"2019","unstructured":"Paschalis A, Sheehan B, Riisnaes R, Rodrigues DN, Gurel B, Bertan C, et al. Prostate-specific membrane antigen heterogeneity and DNA repair defects in prostate cancer. Eur Urol. 2019;76:469\u201378.","journal-title":"Eur Urol"},{"key":"3843_CR22","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41413-021-00178-6","volume":"10","author":"JA Siddiqui","year":"2022","unstructured":"Siddiqui JA, Seshacharyulu P, Muniyan S, Pothuraju R, Khan P, Vengoji R, et al. GDF15 promotes prostate cancer bone metastasis and colonization through osteoblastic CCL2 and RANKL activation. Bone Res. 2022;10:6.","journal-title":"Bone Res"},{"key":"3843_CR23","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1016\/j.ajpath.2024.03.015","volume":"194","author":"A Tubita","year":"2024","unstructured":"Tubita A, Menconi A, Lombardi Z, Tusa I, Espar\u00eds-Ogando A, Pandiella A, et al. Latent-transforming growth factor \u03b2-binding protein 1\/transforming growth factor \u03b21 complex drives antitumoral effects upon ERK5 targeting in melanoma. Am J Pathol. 2024;194:1581\u201391.","journal-title":"Am J Pathol"},{"key":"3843_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.102000","volume":"6","author":"S Yang","year":"2025","unstructured":"Yang S, Qiu X, Yang Y, Wu J, Wang S, Zheng B, et al. LTA4H improves the tumor microenvironment and prevents HCC progression via targeting the HNRNPA1\/LTBP1\/TGF-\u03b2 axis. Cell Rep Med. 2025;6:102000.","journal-title":"Cell Rep Med"},{"key":"3843_CR25","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1002\/j.1460-2075.1991.tb08049.x","volume":"10","author":"K Miyazono","year":"1991","unstructured":"Miyazono K, Olofsson A, Colosetti P, Heldin CH. A role of the latent TGF-beta 1-binding protein in the assembly and secretion of TGF-beta 1. EMBO J. 1991;10:1091\u2013101.","journal-title":"EMBO J"},{"key":"3843_CR26","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/23293","volume":"400","author":"H Zhu","year":"1999","unstructured":"Zhu H, Kavsak P, Abdollah S, Wrana JL, Thomsen GH. A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation. Nature. 1999;400:687\u201393.","journal-title":"Nature"},{"key":"3843_CR27","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41594-024-01221-w","volume":"31","author":"S Rahman","year":"2024","unstructured":"Rahman S, Wolberger C. Breaking the K48-chain: linking ubiquitin beyond protein degradation. Nat Struct Mol Biol. 2024;31:216\u20138.","journal-title":"Nat Struct Mol Biol"},{"key":"3843_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajur.2015.11.002","volume":"3","author":"AM Blee","year":"2016","unstructured":"Blee AM, Huang H. PMEPA1 guards against TGF-\u03b2-mediated prostate cancer bone metastasis. Asian J Urol. 2016;3:1\u20133.","journal-title":"Asian J Urol"},{"key":"3843_CR29","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/bjc.2017.212","volume":"117","author":"Y Dai","year":"2017","unstructured":"Dai Y, Ren D, Yang Q, Cui Y, Guo W, Lai Y, et al. The TGF-\u03b2 signalling negative regulator PICK1 represses prostate cancer metastasis to bone. Br J Cancer. 2017;117:685\u201394.","journal-title":"Br J Cancer"},{"key":"3843_CR30","doi-asserted-by":"crossref","unstructured":"Hao Y, Baker D, Ten Dijke P. TGF-\u03b2-mediated epithelial-mesenchymal transition and cancer metastasis. Int J Mol Sci 2019; 20:2767.","DOI":"10.3390\/ijms20112767"},{"key":"3843_CR31","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41586-019-1897-5","volume":"577","author":"J Su","year":"2020","unstructured":"Su J, Morgani SM, David CJ, Wang Q, Er EE, Huang YH, et al. TGF-\u03b2 orchestrates fibrogenic and developmental EMTs via the RAS effector RREB1. Nature. 2020;577:566\u201371.","journal-title":"Nature"},{"key":"3843_CR32","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/cr.2009.5","volume":"19","author":"J Xu","year":"2009","unstructured":"Xu J, Lamouille S, Derynck R. TGF-beta-induced epithelial to mesenchymal transition. Cell Res. 2009;19:156\u201372.","journal-title":"Cell Res"},{"key":"3843_CR33","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41586-022-05475-6","volume":"612","author":"S Yuan","year":"2022","unstructured":"Yuan S, Stewart KS, Yang Y, Abdusselamoglu MD, Parigi SM, Feinberg TY, et al. Ras drives malignancy through stem cell crosstalk with the microenvironment. Nature. 2022;612:555\u201363.","journal-title":"Nature"},{"key":"3843_CR34","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/ncb890","volume":"4","author":"S Beck","year":"2002","unstructured":"Beck S, Le Good JA, Guzman M, Ben Haim N, Roy K, Beermann F, et al. Extraembryonic proteases regulate Nodal signalling during gastrulation. Nat Cell Biol. 2002;4:981\u20135.","journal-title":"Nat Cell Biol"},{"key":"3843_CR35","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/0092-8674(90)90069-Q","volume":"61","author":"T Kanzaki","year":"1990","unstructured":"Kanzaki T, Olofsson A, Mor\u00e9n A, Wernstedt C, Hellman U, Miyazono K, et al. TGF-beta 1 binding protein: a component of the large latent complex of TGF-beta 1 with multiple repeat sequences. Cell. 1990;61:1051\u201361.","journal-title":"Cell"},{"key":"3843_CR36","doi-asserted-by":"publisher","first-page":"12477","DOI":"10.1074\/jbc.C100008200","volume":"276","author":"T Ebisawa","year":"2001","unstructured":"Ebisawa T, Fukuchi M, Murakami G, Chiba T, Tanaka K, Imamura T, et al. Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation. J Biol Chem. 2001;276:12477\u201380.","journal-title":"J Biol Chem"},{"key":"3843_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-020-01722-w","volume":"21","author":"YY Chen","year":"2021","unstructured":"Chen YY, Zhang XN, Xu CZ, Zhou DH, Chen J, Liu ZX, et al. MCCC2 promotes HCC development by supporting leucine oncogenic function. Cancer Cell Int. 2021;21:22.","journal-title":"Cancer Cell Int"},{"key":"3843_CR38","doi-asserted-by":"publisher","first-page":"4213","DOI":"10.1021\/jm500115w","volume":"57","author":"CH Jin","year":"2014","unstructured":"Jin CH, Krishnaiah M, Sreenu D, Subrahmanyam VB, Rao KS, Lee HJ, et al. Discovery of N-((4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl)methyl)-2-fluoroaniline (EW-7197): a highly potent, selective, and orally bioavailable inhibitor of TGF-\u03b2 type I receptor kinase as a cancer immunotherapeutic\/antifibrotic agent. J Med Chem. 2014;57:4213\u201338.","journal-title":"J Med Chem"},{"key":"3843_CR39","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1158\/1535-7163.MCT-13-0903","volume":"13","author":"JY Son","year":"2014","unstructured":"Son JY, Park SY, Kim SJ, Lee SJ, Park SA, Kim MJ, et al. EW-7197, a novel ALK-5 kinase inhibitor, potently inhibits breast to lung metastasis. Mol Cancer Ther. 2014;13:1704\u201316.","journal-title":"Mol Cancer Ther"},{"key":"3843_CR40","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13045-021-01053-x","volume":"14","author":"BG Kim","year":"2021","unstructured":"Kim BG, Malek E, Choi SH, Ignatz-Hoover JJ, Driscoll JJ. Novel therapies emerging in oncology to target the TGF-\u03b2 pathway. J Hematol Oncol. 2021;14:55.","journal-title":"J Hematol Oncol"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03843-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03843-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03843-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T22:03:49Z","timestamp":1783375429000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03843-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,6]]},"references-count":40,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2026,7,28]]}},"alternative-id":["3843"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03843-4","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,6]]},"assertion":[{"value":"25 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study adhered to the principles outlined in the Declaration of Helsinki and was approved by the Medical Ethics Committee of the Fifth Affiliated Hospital of Sun Yat-sen University (Approval No. 2023-S-03). Animal care and experimental procedures were approved by the Animal Ethics Committee and conducted in the Fifth Affiliated Hospital of Sun Yat-sen University (Approval No. #00261).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}